Fujisawa, Japan

Ryosuke Arai



Average Co-Inventor Count = 10.5

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Fujisawa, JP (2019)
  • Kanagawa, JP (2019)

Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ryosuke Arai: Innovator in Pharmaceutical Compounds

Introduction

Ryosuke Arai is a notable inventor based in Fujisawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address critical health issues. With a total of 3 patents to his name, Arai's work is focused on innovative solutions for various diseases.

Latest Patents

Arai's latest patents include a heterocyclic compound that is useful for the treatment or prevention of SPT-related diseases, including cancer and congenital diseases associated with sphingolipid accumulation, such as Niemann-Pick disease. Another significant patent is for a nitrogen-containing heterocyclic compound, which acts as a cholinergic muscarinic M1 receptor positive allosteric modulator. This compound is intended for use as a medicament for conditions such as Alzheimer's disease, schizophrenia, pain, sleep disorders, and Parkinson's disease dementia.

Career Highlights

Ryosuke Arai is currently employed at Takeda Pharmaceutical Company Limited, a leading global biopharmaceutical company. His work at Takeda has allowed him to focus on innovative research and development in the pharmaceutical sector. Arai's contributions have been instrumental in advancing the company's mission to improve patient outcomes through innovative therapies.

Collaborations

Arai collaborates with talented colleagues, including Yasutomi Asano and Takuto Kojima. Their combined expertise fosters a productive environment for innovation and research.

Conclusion

Ryosuke Arai is a distinguished inventor whose work in pharmaceutical compounds has the potential to make a significant impact on healthcare. His innovative patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…